Neovasc and Boston Scientific Reach US$75 Million Agreement
- Boston Scientific acquires tissue processing capabilities and takes equity stake in Neovasc - NASDAQ: NVCNTSX: NVC VANCOUVER, Dec. 2, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, has...
Read More